Speaker Profile
NOBEL LAUREATE, Ph.D., Professor of Molecular Biology and Genetics, UCSC
Biography
Dr. Carol Greider was awarded the 2009 Nobel Prize in Physiology or Medicine by the Royal Swedish Academy of Sciences. The Academy recognized her for her 1984 discovery of telomerase, an enzyme that maintains the length and integrity of chromosome ends and is critical for the health and survival of all living cells and organisms. Dr. Greiders discovery of telomerase a remarkable enzyme that restores telomeres and protects them from damage catalyzed an explosion of scientific studies which, to this day, probe connections between telomerase and telomeres to human cancer and diseases of aging.Greider shares the prize with Elizabeth Blackburn, a professor of biochemistry and biophysics at the University of California, San Francisco, and Jack Szostak of Harvard Medical School.
Session Abstract – PMWC 2025 Silicon Valley
Track 4
Track Chair: Kathleen Barnes, Oxford Nanopore
Speakers:
Nobel Laureate Carol Greider, UCSC
Orit Rozenblatt-Rosen, Genentech
Emily Leproust, Twist
Session: Unraveling the molecular drivers of cancer requires a comprehensive understanding of its genetic, epigenetic, and proteomic complexities. This session explores how multi-omic technologies decode these intricate layers, providing insights into cancer's initiation, growth, and progression. By integrating diverse molecular data, researchers are uncovering actionable biomarkers, identifying therapeutic targets, and paving the way for breakthroughs in precision oncology. Join leading experts as they share cutting-edge advancements and strategies to overcome challenges in translating multi-omic research into clinical impact.
